NextCure, Inc.NXTCNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank50
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-57.62M
↓ 15% vs avg
Percentile
P50
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
$-49.90M
Historical baseline
PeriodValueYoY Change
TTM$-57.62M+3.6%
2024$-59.75M+11.7%
2023$-67.64M+10.9%
2022$-75.91M-7.3%
2021$-70.77M-71.7%
2020$-41.23M-10.0%
2019$-37.48M-61.6%
2018$-23.20M-49.2%
2017$-15.55M-